Literature DB >> 31924708

Yolk sac tumour of ovary with fever and overt hypothyroidism: rare clinical presentation.

Megha Kansara1, Garima Yadav2, Meenakshi Gothwal2, Pratibha Singh2.   

Abstract

Yolk sac tumours of the ovary are rare and highly malignant germ cell tumours, which comprise of only 10%-15% of all malignant germ cell tumours. They have various clinical presentations most common being subacute pelvic pain and feeling of lump but sometimes high-grade fever can be one of the rare presentations. Here, we present a case report of a 26-year-old nulliparous woman with 36 weeks gravid uterus size advanced stage yolk sac tumour of one ovary with fever as main clinical presentation and overt hypothyroidism. We did staging laparotomy with total abdominal hysterectomy with bilateral salpingo-oophorectomy and omentectomy with multiple peritoneal biopsies. Postoperatively, we had started adjuvant chemotherapy. Since yolk sac tumours are highly aggressive tumours as they rapidly increase in size, their early diagnosis and appropriate surgical management is required particularly in young women where fertility sparing surgery is possible in early stage with good prognosis. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  cancer; cancer - see oncology; chemotherapy; obstetrics and gynaecology; pregnancy

Mesh:

Year:  2020        PMID: 31924708      PMCID: PMC6954795          DOI: 10.1136/bcr-2019-232114

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  6 in total

1.  Malignant germ cell tumors of the ovary.

Authors:  K Tewari; F Cappuccini; P J Disaia; M L Berman; A Manetta; M F Kohler
Journal:  Obstet Gynecol       Date:  2000-01       Impact factor: 7.661

2.  Incidence and survival rates for female malignant germ cell tumors.

Authors:  Harriet O Smith; Marianne Berwick; Claire F Verschraegen; Charles Wiggins; Letitia Lansing; Carolyn Y Muller; Clifford R Qualls
Journal:  Obstet Gynecol       Date:  2006-05       Impact factor: 7.661

3.  Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  I Ray-Coquard; P Morice; D Lorusso; J Prat; A Oaknin; P Pautier; N Colombo
Journal:  Ann Oncol       Date:  2018-10-01       Impact factor: 32.976

4.  Neo-adjuvant chemotherapy in the treatment of advanced malignant germ cell tumors of ovary.

Authors:  Shobhana Talukdar; Sunesh Kumar; Neerja Bhatla; S Mathur; S Thulkar; Lalit Kumar
Journal:  Gynecol Oncol       Date:  2013-10-19       Impact factor: 5.482

5.  Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group.

Authors:  S Williams; J A Blessing; S Y Liao; H Ball; P Hanjani
Journal:  J Clin Oncol       Date:  1994-04       Impact factor: 44.544

6.  Endodermal sinus tumor of the ovary: a clinical and pathologic analysis of 71 cases.

Authors:  R J Kurman; H J Norris
Journal:  Cancer       Date:  1976-12       Impact factor: 6.860

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.